Relationship between Thyroid Volume and Baseline Vitamin D Levels in New-Onset Graves Disease

Gülşah Yenidünya Yalın; Hüseyin Çelik; Fuat Cenik; Serkan Feyyaz Yalın

doi:10.5152/EurJTher.2018.607

Authors

Gülşah Yenidünya Yalın Division of Endocrinology and Metabolism Disorders, Başkent University, School of Medicine, İstanbul https://orcid.org/0000-0002-9013-5237
Hüseyin Çelik Clinic of Endocrinology and Metabolism Disorders, Kanuni Sultan Süleyman Training and Research Hospital, İstanbul
Fuat Cenik https://orcid.org/0000-0003-2063-541X
Serkan Feyyaz Yalın Clinic of Nephrology, Kartal Dr. Lütfi Kırdar Training and Research Hospital, İstanbul https://orcid.org/0000-0002-8146-6966

DOI:

https://doi.org/10.5152/EurJTher.2018.607

Keywords:

Autoimmune disorders, 25 (OH) vitamin D, TRAb, Graves disease, thyroid volume

Abstract

Objective: Serum vitamin D is shown to be decreased and associated with higher thyroid volumes in Graves disease (GD). We aimed to investigate the relationship between thyroid volume and baseline serum vitamin D status in newly diagnosed GD patients.
Methods: This was a single-center cross-sectional study with a total of 61 new-onset GD patients (n=61, F: 40, M: 21) who were divided into two groups, according to baseline serum vitamin D levels, as Group-1 (vitamin D <20; n: 42) and Group-2 (vitamin D ≥20; n=19). Thyroid volume (mL) and isthmus measurements (mm) were compared between the two groups.
Results: There was an inverse correlation between the baseline serum vitamin D levels and thyroid volume, thyroid receptor autoantibodies (TRAb), free triiodothyronine (fT3), and parathyroid hormone (PTH) levels (p=0.02, r=-0.31; p=0.005, r=-0.36; p=0.04, r=-0.26; p=0.02, r=-0.32, respectively). Thyroid volume was also correlated with serum free thyroxine (fT4), fT3, TRAb, and thyroid peroxidase autoantibodies (TPOAb; p=0.001, r=0.426; p=0.001, r=0.50; p=0.04, r=0.26; p=0.001, r=0.42, respectively). Low vitamin D and high thyroglobulin antibody (TgAb) levels were significantly associated with thyroid volume based on a regression analysis (p=0.03, odds ratio [OR]:18.7, 95% confidence interval [CI]: 1.34-260.91 and p=0.04, OR: 16.6, 95% CI: 1.07-255.64, respectively).
Conclusion: Baseline serum vitamin D levels are inversely related with thyroid volumes, fT3, and TRAb levels in new-onset GD. In addition to several advantages, optimization of vitamin D levels would also be beneficial in the surveillance of these patients. However, larger scale studies are required to make further suggestions.

Metrics

Metrics Loading ...

References

Bizzaro G, Shoenfeld Y. Vitamin D and autoimmune thyroid diseases: facts and unresolved questions. Immunol Res 2015; 61: 46-52.

Vondra K, Starka L, Hampl R. Vitamin D and Thyroid Diseases. Physiol Res 2015; 64: 95-100.

Kivity S, Agmon-Levin N, Zisappl M, Shapira Y, Nagy EV, Danko K et al. Vitamin D and autoimmune thyroid diseases. Cell Mol Immunol 2011; 8: 243-7.

Kurylowicz A, Ramos-Lopez E, Bednarczuk T, Badenhoop K. Vitamin D-binding protein (DBP) gene polymorphism is associated with Graves’ disease and the vitamin D status in a Polish population study. Exp Clin Endocrinol 2006; 114: 329-35.

Abd el Gawad SS, Samee Er Abdul, Metwali AA, Abd el Gawad MS. Vitamin D receptor gene polymorphism and its association with 1,25-dihydroxyvitamin D in patients with Graves disease in an Egyptian population: a pilot study. Endocr Pract 2012; 18: 132-9.

Ramos-Lopez E, Kurylowicz A, Bednarczuk T, Paunkovic J, Seidl C, Badenhoop K. Vitamin D receptor polymorphisms are associated with Graves’ disease in German and Polish but not in Serbian patients. Thyroid 2015; 15: 1125-30.

Yasuda T, Okamoto Y, Hamada N, Miyashita K, Takahara M, Sakamoto F. Serum vitamin D levels are decreased and associated with thyroid volume in female patients with newly onset Graves’ disease. Endocrine 2012; 42: 739-41.

Yasuda T, Okamoto Y, Hamada N, Miyashita K, Takahara M, Sakamoto F, et al. Serum vitamin D levels are decreased in patients without remission of Graves’ disease. Endocrine 2013; 43: 230-2.

Hollick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-81.

Shabana W, Peeters E, De Maeseneer M. Measuring thyroid gland volume: should we change the correction factor? AJR Am J Roentgenol 2006; 186: 234-6.

Yin K, Agrawal DK. Vitamin D and inflammatory diseases. J Inflamm Res 2014; 7: 69-87.

Bouillon R. Vitamin D: from photosynthesis, metabolism and action to clinical applications. In: Endocrinology, Jameson JL, De Groot LJ, Saunders Elsevier, Philadelphia 2010.

Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C. Vitamin D: modulator of the immune system. Curr Opin Pharmacol 2010; 10: 482-96.

Li YB, Xue XH, Liu SW, Xi GX, Zhao LX, Zhang XL. Clinical research of serum vitamin D in early Graves disease. Chin Rem Clin 2014; 14: 242-3.

Miao W, Ma J, Guo R, Wang YJ, Wang G, Guan HX. Research about the correlation between Serum 25(OH)D with Graves’ disease. Chin. J Pract Internal Med 2013; 33: 394-95.

Fournier C, Gepner P, Sadouk M. In vivo beneficial effects of cyclosporin A and 1,25-dihydroxyvitamin D3 on the induction of experimental autoimmune thyroiditis. Clin Immunol Immunopathol 1990; 54: 53-63.

Choi YM, Kim WG, Kim TY. Low levels of serum vitamin D3 are associated with autoimmune thyroid disease in pre-menopausal women. Thyroid 2014; 24: 655-61.

Zhang H, Liang L, Xie Z. Low vitamin D status is associated with increased titers of thyroid stimulating hormone receptor antibodies in Graves disease. Endocr Pract 2015; 21: 258-63.

Feng M, Li H, Chen SF. Polymorphisms in the vitamin D receptor gene and risk of autoimmune thyroid diseases: a meta-analysis. Endocrine 2013; 43: 318-26.

Xu MY, Cao B, Yin J, Wang DF, Chen KL, Lu QB. Vitamin D and Graves’ Disease: A Meta-Analysis Update.Nutrients 2015; 7: 3813-27.

Effraimidis G, Wiersinga WM. Mechanisms in endocrinology: autoimmune thyroid disease: old and new players. Eur J Endocrinol 2014; 170: 241-52.

Inoue N, Watanabe M, Ishido N. The functional polymorphisms of VDR, GC and CYP2R1 are involved in the pathogenesis of autoimmune thyroid diseases. Clin Exp Immunol 2014; 178: 262-9.

Yazici D, Yavuz D, Tarcin O. Vitamin D receptor gene ApaI, TaqI, FokI and BsmI polymorphisms in a group of Turkish patients with Hashimoto’s thyroiditis. Minerva Endocrinol 2013; 38: 195-201.

Pantazi H, Papapetrou PD. Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism. J Clin Endocrinol Metab 2000; 83: 1099-106.